Welcome Guest | Register / Login

Pharmaceuticals Market Research Reports

Sort By
Title Published Price Buy Now
Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 - 2015)
By Renub Research
Schizophrenia - Market Overview Schizophrenia is a mental disorder characterized by disintegration of thought processes and of emotional responsiveness. It most commonly manifests as auditory hallucinations, paranoid or bi...
Aug 2011 $ 850
Global Hepatitis C Virus (HCV) Market - An Analysis
By Koncept Analytics
Report Summary Hepatitis C virus (HCV) is commonly spread through blood from a person who has been infected through use of shared needles or equipment used to...
Aug 2011 $ 800
Kinase-Targeted Therapeutics: Development Pipelines, Challenges, and Opportunities
By Insight Pharma Reports
The field of kinase modulation is one of the most active in the biopharmaceutical industry. About 20 kinase inhibitors are approved for marketing in the United States and at least another 250 are in clinical evaluation. Kinases make up a veritable...
Aug 2011 $ 595
Pharma Marketing Excellence: Lessons From Experiences
By Insight Pharma Reports
Marketing excellence. Over the past five years, those two words have been the subject of hype and the focus of management attention. As the pharmaceutical industry struggles with market maturation and weakening product pipelines, marketing excelle...
Aug 2011 $ 595
The Impact of iPad on Pharma: A Primer
By Insight Pharma Reports
With the launch of Apple's iPad in April 2010, the way we use technology changed forever. Instant, portable and quick, the iPad is expected to sell 50 million units in 2011 alone.Its impact on Pharma is still being measured, but fo...
Jul 2011 $ 295
Alzheimer's Disease Patients & Market Worldwide, Future Scenario (2010 - 2015) & Drugs Analysis
By Renub Research
Overview Alzheimer’s is a complex disease and there is no single “magic bullet” available in the market to prevent or cure it. Though many marketed drugs have been approved for Alzheimer’s disease, ...
Jun 2011 $ 950
Brazil Diabetes Market Report & Forecast 2011-2016
By IMARC Group
Report SummaryIMARC’s new report “Brazil Diabetes Market Report & Forecast 2011-2016” provides an analytical and statistical insight into...
May 2011 $ 750
Canada Diabetes Market Report & Forecast 2011-2016
By IMARC Group
Report SummaryIMARC’s new report “Canada Diabetes Market Report & Forecast 2011-2016” provides an analytical and statistical insight into...
May 2011 $ 750
Russia Diabetes Market Report & Forecast 2011-2016
By IMARC Group
Report SummaryIMARC’s new report “Russia Diabetes Market Report & Forecast 2011-2016” provides an analytical and statistical insight into...
May 2011 $ 750
Turkey Diabetes Market Report & Forecast 2011-2016
By IMARC Group
Report SummaryIMARC’s new report “Turkey Diabetes Market Report & Forecast 2011-2016” provides an analytical and statistical insight into...
May 2011 $ 750
Italy Diabetes Market Forecast 2011-2016
By IMARC Group
Report SummaryIMARC’s new report “Italy Diabetes Market Forecast 2011-2016” provides an analytical and statistical insight into the Italian d...
Mar 2011 $ 750
France Diabetes Market Forecast 2011-2016
By IMARC Group
Report SummaryIMARC’s new report “France Diabetes Market Forecast 2011-2016” provides an analytical and statistical insight into the French d...
Mar 2011 $ 750
Biosimilars Regulatory Update: an evolving landscape
By Insight Pharma Reports
They’re costly to develop, fraught with potential patient safety concerns and subject to regulations that have yet to be written.Yet for the pharmaceutical industry, biosimilar monoclonal antibodies (mAbs) represent a potential treasu...
Feb 2011 $ 395
The 2011-2016 World Outlook for Non-Small Cell Lung Cancer Therapeutics
By ICON Group International, Inc.
This econometric study covers the world outlook for non-small cell lung cancer therapeutics across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country...
Jan 2011 $ 795
The European Pharmaceutical Directory 2011
By Asia Pacific InfoServ Pty Ltd
Report SummaryThe market potential of the European biotechnology and pharmaceutical sector is enormous and business opportunities abound. However, unraveling the maze of who’s who,...
Jan 2011 $ 376
The 2011-2016 Outlook for Non-Small Cell Lung Cancer Therapeutics in Greater China
By ICON Group International, Inc.
This econometric study covers the latent demand outlook for non-small cell lung cancer therapeutics across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipaliti...
Jan 2011 $ 495